BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36528041)

  • 1. Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study.
    Rodríguez-Perálvarez ML; Gómez-Orellana AM; Majumdar A; Bailey M; McCaughan GW; Gow P; Guerrero M; Taylor R; Guijo-Rubio D; Hervás-Martínez C; Tsochatzis EA
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):242-252. PubMed ID: 36528041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation.
    Marrone G; Giannelli V; Agnes S; Avolio AW; Baiocchi L; Berardi G; Ettorre GM; Ferri F; Corradini SG; Grieco A; Guglielmo N; Lenci I; Lionetti R; Mennini G; Milana M; Rossi M; Spoletini G; Tisone G; Manzia TM; Lai Q
    Liver Int; 2024 Jan; 44(1):103-112. PubMed ID: 37752798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting List.
    Asrani SK; Jennings LW; Kim WR; Kamath PS; Levitsky J; Nadim MK; Testa G; Leise MD; Trotter JF; Klintmalm G
    Hepatology; 2020 May; 71(5):1766-1774. PubMed ID: 31523825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score.
    Beal EW; Akateh C; Tumin D; Bagante F; Black SM; Washburn K; Azouley D; Pawlik TM
    Exp Clin Transplant; 2020 Aug; 18(4):491-497. PubMed ID: 31050611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model including standardized weight improved predicting waiting list mortality in adolescent liver transplant candidates: A US national study.
    Shaheen AA; Martin SR; Khorsheed S; Abraldes JG
    Liver Transpl; 2024 Mar; 30(3):269-276. PubMed ID: 37655999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region.
    Goudsmit BFJ; Putter H; Tushuizen ME; de Boer J; Vogelaar S; Alwayn IPJ; van Hoek B; Braat AE
    Am J Transplant; 2021 Jan; 21(1):229-240. PubMed ID: 32529758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation.
    Allen AM; Heimbach JK; Larson JJ; Mara KC; Kim WR; Kamath PS; Therneau TM
    Transplantation; 2018 Oct; 102(10):1710-1716. PubMed ID: 29620614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD-Na Alterations on the Liver Transplant Waiting List and Their Impact on Listing Outcome.
    Silberhumer GR; Györi G; Brugger J; Baumann L; Zehetmayer S; Soliman T; Berlakovich G
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recipient age on prioritisation for liver transplantation in the UK: a population-based modelling study.
    Attia A; Webb J; Connor K; Johnston CJC; Williams M; Gordon-Walker T; Rowe IA; Harrison EM; Stutchfield BM
    Lancet Healthy Longev; 2024 May; 5(5):e346-e355. PubMed ID: 38705152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint modeling of liver transplant candidates outperforms the model for end-stage liver disease: The effect of disease development over time on patient outcome.
    Goudsmit BFJ; Braat AE; Tushuizen ME; Vogelaar S; Pirenne J; Alwayn IPJ; van Hoek B; Putter H
    Am J Transplant; 2021 Nov; 21(11):3583-3592. PubMed ID: 34174149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MELD-GRAIL and MELD-GRAIL-Na Are Not Superior to MELD or MELD-Na in Predicting Liver Transplant Waiting List Mortality at a Single-center Level.
    Chetwood JD; Wells MG; Tsoutsman T; Pulitano C; Crawford MD; Liu K; Strasser SI; McCaughan GW; Majumdar A
    Transplant Direct; 2022 Jul; 8(7):e1346. PubMed ID: 35706607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-weighting the model for end-stage liver disease score components.
    Sharma P; Schaubel DE; Sima CS; Merion RM; Lok AS
    Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The royal free hospital cirrhosis glomerular filtration rate.
    Kalafateli M; Wickham F; Burniston M; Cholongitas E; Theocharidou E; Garcovich M; O'Beirne J; Westbrook R; Leandro G; Burroughs AK; Tsochatzis EA
    Hepatology; 2017 Feb; 65(2):582-591. PubMed ID: 27779785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System.
    Ahn DJ; Zeng S; Pelzer KM; Barth RN; Gallo A; Parker WF
    Transplantation; 2023 Oct; 107(10):e247-e256. PubMed ID: 37408100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.